Register Free at www.biopharminternational.com/highcapacity Event Overview: The past 15 years have seen advances in biotechnology that have allowed the increased use of monoclonal antibodies (mAbs) as the main constituent of therapeutic drugs. With the increased commercial utilization of these molecules, it is imperative that chromatographers have access to the tools necessary to develop purification processes that maximize productivity while keeping operating costs to a minimum.  This presentation will discuss the use of High Capacity Protein A resins as a productivity enhancer in the monoclonal antibody capture step, and how the use of these resins can influence purification steps further downstream. Key Learning Objectives: Advantages to the use of High Capacity Protein A resins Upstream influences on the use of High Capacity Protein A resins Downstream effects of the use of High Capacity Protein A resins Who Should Attend: Chromatographers, method developers, and process engineers looking to improve their purification process with the inclusion of a High Capacity Protein A step For questions, contact Kristen Farrell at kfarrell@advanstar.com Presenters: J. Kevin O’Donnell, PhD Director of Technical Service Tosoh Bioscience LLC Moderator:   Reid Paul Multi-Media Editor BioPharm International Sponsors: Presented by: Sponsored by: